Cargando…
2′,3′,4′-Trihydroxychalcone changes estrogen receptor α regulation of genes and breast cancer cell proliferation by a reprogramming mechanism
BACKGROUND: Menopausal hormone therapy (MHT) is recommended for only five years to treat vasomotor symptoms and vulvovaginal atrophy because of safety concerns with long-term treatment. We investigated the ability of 2′,3′,4′-trihydroxychalcone (2′,3′,4′-THC) to modulate estrogen receptor (ER)-media...
Autores principales: | Herber, Candice B., Yuan, Chaoshen, Chang, Anthony, Wang, Jen-Chywan, Cohen, Isaac, Leitman, Dale C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036729/ https://www.ncbi.nlm.nih.gov/pubmed/35468719 http://dx.doi.org/10.1186/s10020-022-00470-z |
Ejemplares similares
-
Effects of 2,2′,4′-trihydroxychalcone on the proliferation, metastasis and apoptosis of A549 human lung cancer cells
por: Sun, Jia-Lin, et al.
Publicado: (2022) -
Drug and Cell Type-Specific Regulation of Genes with Different Classes of Estrogen Receptor β-Selective Agonists
por: Paruthiyil, Sreenivasan, et al.
Publicado: (2009) -
Parabens and Human Epidermal Growth Factor Receptor Ligand Cross-Talk in Breast Cancer Cells
por: Pan, Shawn, et al.
Publicado: (2015) -
Effectiveness of the Natural Antioxidant 2,4,4′-Trihydroxychalcone on the Oxidation of Sunflower Oil during Storage
por: Alsufiani, Hadeil, et al.
Publicado: (2021) -
The Plant-Derived Chalcone 2,2′,5′-Trihydroxychalcone Provides Neuroprotection against Toll-Like Receptor 4 Triggered Inflammation in Microglia
por: Jiwrajka, Manasi, et al.
Publicado: (2016)